In HCC, CD44 and CD133 are common cancer stem cell (CSC) markers, CD133+ cells have stronger proliferation ability and tumorigenicity than CD133 cells, while CD44 provides a unique cellular signature for CD133+ or CD90+ CSCs in HCC (31, 32). The gene discussed is THY1; the disease is hepatocellular carcinoma.